Vanda shareholders elect directors, ratify auditor, approve say-on-pay and equity plan amendment

Vanda Pharmaceuticals Inc.

Quorum of 46,577,816 shares (79.0%) represented at June 5, 2025 annual meeting.
Directors Stephen Ray Mitchell and Tage Honoré elected with ~31.5M and ~31.3M votes for, respectively.
Ratification of PricewaterhouseCoopers LLP as auditor for FY2025: 43.8M for, 2.3M against.
Advisory say-on-pay approved: 28.6M for, 10.1M against, 7.7M broker non-votes.
Amendment to 2016 Equity Incentive Plan (increase shares, eliminate term) approved: 33.0M for, 5.7M against.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.